about
The therapeutic potential of metal-based antimalarial agents: implications for the mechanism of actionFerrocene-based antimalarialsCholine analogues in malaria chemotherapyIn vitro and in vivo antischistosomal activity of ferroquine derivatives.Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agentsIdentification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusA Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.Introducing New Antimalarial Analogues of Chloroquine and Amodiaquine: A Narrative Review.New insight-guided approaches to detect, cure, prevent and eliminate malaria.Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum MalaThe antimalarial ferroquine is an inhibitor of hepatitis C virus.Single dose treatment of malaria - current status and perspectives.Iminosugar-ferrocene conjugates as potential anticancer agents.Antiplasmodial activity of targeted zinc(II)-dipicolylamine complexes.Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties.Opening up the advantages of the ruthenocenic bioprobes of ferroquine: distribution and localization in Plasmodium falciparum-infected erythrocytes.7-chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation.Synthesis and in vitro anti-tubercular evaluation of 1,2,3-triazole tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone chimeric scaffolds.In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates.Ferroquine, the next generation antimalarial drug, has antitumor activity.Quinoline-Based Hybrid Compounds with Antimalarial Activity.Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes.A new route for the synthesis of highly substituted 4-aminoquinoline drug like molecules via aza hetero-Diels-Alder reaction.Current and Future Strategies for Improving Drug Discovery Efficiency
P2860
Q20906133-5A6ED50E-71ED-459F-9E18-3555668B4637Q21032535-E840B617-DCED-41AB-A2BA-4BF1C5D5C888Q26851323-DEB8C003-B0EF-4CB5-A258-8B82A80C991EQ34185025-76DC5509-96D9-4A2B-A6C8-ED347D36224AQ36018719-67288F16-D9C8-4214-9720-31E18D2A0D61Q36427654-331ACE63-0FDB-475A-AE0D-36487744BEE9Q36914067-DBE2E523-062F-409A-991C-E6549BDE2563Q37252935-2787DBE7-A427-47AD-8E7E-111D8EC3E819Q37254756-6C596DA0-A996-414C-BD93-1C587EC135C3Q37263372-0A597B65-C0B7-493A-BC9D-E8F0AFEA2916Q37721293-AC648CC6-93C9-4847-9FAC-26C941DC331FQ38260909-7A00C5C1-6B86-4E4A-A499-2EBF4DC01FCFQ38655307-9E50104C-2CB7-4D6E-9B17-11571FA446A4Q39205134-418649E4-2C7C-406C-87DA-52BCDA2702E2Q39253978-A16E7AAC-E102-4C85-AA3D-00C2591C6885Q39327878-A4FF98F9-10AE-43C9-9169-08EBB30DEEA7Q39396680-AAC5824F-BC01-48A2-A5B3-8500B8AFA125Q41915835-F96088F6-4E4B-4182-A6EA-85B11432448AQ41929217-648C5BBC-1EB2-41B5-9CF8-2C474538ADADQ42707908-CB1E2FB5-319A-4269-9DDD-250BEE0AE1BAQ42719383-531101B1-7D70-4EFD-B139-F95631F1A0C2Q46250299-4069EC8D-7155-4D33-9C47-2A88E1F5E501Q46783979-1299CFC0-1159-4FA1-ACE6-0A10768504E1Q47098598-23816BBE-657E-40D1-9E52-E1ABD93F029DQ48019642-BD9248C4-E69B-4741-BAFD-B1559FC2A583Q48176143-C1827698-B646-45E7-95D0-A8F92F1A72A6Q50961203-1AFB4198-1D09-42B4-8D49-01BAAFF2DA4EQ58636775-FD3A388E-0E5F-4D16-804F-BFBDFE728FE1
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The antimalarial ferroquine: from bench to clinic.
@ast
The antimalarial ferroquine: from bench to clinic.
@en
The antimalarial ferroquine: from bench to clinic.
@nl
type
label
The antimalarial ferroquine: from bench to clinic.
@ast
The antimalarial ferroquine: from bench to clinic.
@en
The antimalarial ferroquine: from bench to clinic.
@nl
prefLabel
The antimalarial ferroquine: from bench to clinic.
@ast
The antimalarial ferroquine: from bench to clinic.
@en
The antimalarial ferroquine: from bench to clinic.
@nl
P2093
P2860
P921
P356
P1433
P1476
The antimalarial ferroquine: from bench to clinic.
@en
P2093
P2860
P304
P356
10.1051/PARASITE/2011183207
P5008
P577
2011-08-01T00:00:00Z